A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas

Clinical trial NCT02209428 · UNKNOWN

Trial details

NCT number: NCT02209428
Sponsor: Huashan Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Astrocytoma Oligodendroglioma Oligoastrocytoma

Start date: 2014-06-01
Primary completion: 2019-04-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.